Skip to main content

Evaluate and apply the LC/FAIMS/IMS/TOF MS platform to high throughput quantitative analysis


EMSL Project ID
30192

Abstract

One of the goals of the Clinical Proteomic Technologies for Cancer (CPTC) initiative is to evaluate the performance of proteomic technology platforms and standardizing applications of these platforms. The task in this proposal is intended to evaluate the new LC/IMS/TOF MS for its throughput and sensitivity using a protein mixture NCI-20 spplied by NCI

Project Details

Start Date
2008-05-19
End Date
2011-05-22
Status
Closed

Team

Principal Investigator

Keqi Tang
Institution
Pacific Northwest National Laboratory

Team Members

Erin Baker
Institution
North Carolina State University